Developer docs
API playgroundTry for free, no card

Search company profiles

Swiss Stem Cells Biotech

Full company profile

uuid002bsab

Namestring
Swiss Stem Cells Biotech
Legal namestring
Swiss Stem Cells Biotech
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Swiss Stem Cells Biotech (SSCB) is a Swiss private biobank founded in 2005 in Lugano, Switzerland, specializing in the cryopreservation of biological materials including umbilical cord blood and cord tissue (MyBabyCells), adipose-derived adult stem cells (AdultCells), peripheral blood mononuclear cells for induced pluripotent stem cell generation (EternaCell), and DNA. The company operates as one of the few private biobanks holding FACT-NETCORD accreditation and GMP certification in Switzerland, addressing individual consumers (expecting parents and adult patients), medical professionals, and third-party healthcare companies.

The business model combines one-time processing and collection fees with recurring annual storage subscriptions (with entry pricing from CHF 88), supplemented by DNA storage, contract manufacturing for Advanced Therapy Medicinal Products (ATMPs), and medical training through CELLS Academy. SSCB also operates a hybrid public-private banking model approved by the Swiss Federal Office of Public Health (FOPH) in 2020, partnering with the Women's Clinic of Inselspital in Bern and the Blood Transfusion Service of the Swiss Red Cross.

Distribution is achieved through partner hospitals nationwide and membership in international registries such as the World Marrow Donor Association (WMDA). The company operates with a small team of 1-10 employees from a Swiss headquarters, positioning itself as a "100% Swiss" provider in a trust-sensitive consumer category.

Short descriptiontext

Swiss Stem Cells Biotech is a Swiss private biobank founded in 2005, offering cryopreservation of cord blood, adipose tissue, PBMCs, and DNA to consumers and healthcare partners, with FACT-NETCORD accreditation and a unique FOPH-approved hybrid banking model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersVacallo, Switzerland
HQ citystring
Vacallo
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stem cell banking, cord blood storage, biobank services, cryopreservation services, regenerative medicine
Industry2 codes
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAKAC
Cell Therapy Manufacturing Services (GMP, autologous/allogeneic)
NAICS code1 code
  • Blood and Organ Banks621991
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Services-Medical Laboratories8071
Product category
Stem Cell Biobank Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Stem Cell Cryopreservation Services
TypeSubscription Recurring
Description

Recurring storage fees for cryopreservation of stem cells from umbilical cord blood, cord tissue, placental tissue, and adipose tissue. One-time processing fees combined with ongoing annual storage charges.

sscb-stembiotech.ch
2DNA Storage Services
TypeOne Time License
Description

One-time or recurring fees for genetic code preservation services.

sscb-stembiotech.ch
3Contract Manufacturing (ATMPs)
TypeProfessional Services
Description

Consultation, development, validation, approval, and production of tissue engineering and advanced biological products on behalf of third parties.

sscb-stembiotech.ch
4CELLS Academy Training
TypeProfessional Services
Description

Courses for medical professionals on regenerative medicine and minimally invasive surgery techniques.

sscb-stembiotech.ch
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details1 tier
1Stem Cell Storage starting from CHF 88
ModelSubscriptionBilling cadenceMonthly
Notes

Contact required for detailed pricing information

sscb-stembiotech.ch
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Swiss Stem Cells Biotech is a Swiss-certified private biobank that processes and cryopreserves stem cells collected from umbilical cord blood, cord tissue, placental tissue, and adult adipose tissue. Samples are transported directly from partner hospital delivery rooms to its own GMP-certified, FACT-NETCORD accredited laboratory in Switzerland for processing and long-term storage, with a subscription-based storage model complemented by ancillary services such as DNA preservation, contract manufacturing of Advanced Therapy Medicinal Products (ATMPs), and professional training via CELLS Academy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Applications in more than 80 established diseases
+1 more record
Product overview1 text field

Swiss Stem Cells Biotech operates as a Swiss-certified family biobank offering a portfolio of biological preservation services. The core offerings include MyBabyCells (umbilical cord blood and tissue banking) and AdultCells (adipose tissue stem cell banking for adult patients), supported by specialized services like EternaCell (peripheral blood mononuclear cell preservation) and DNA storage. The company offers contract manufacturing for ATMPs and advanced biological products. CELLS Academy provides educational courses for medical professionals. The Hybrid Banking Model represents a unique public-private partnership enabling family banking with optional anonymous donation to the global WMDA registry.

Product and service7 records
1MyBabyCells
CategoryStem Cell Banking
Description

Stem cell banking service that collects, transports, processes, and cryopreserves stem cells from a newborn's umbilical cord blood and cord tissue for potential future family therapeutic use.

2AdultCells
3EternaCell
4Hybrid Banking Model
CategoryStem Cell Banking
Description

Combined family protection and public donation model that allows cord blood samples to be entered into the World Marrow Donor Association (WMDA) global registry with explicit consent.

5DNA Storage
6Contract Manufacturing (ATMPs)
7CELLS Academy
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Women's Clinic of Inselspital in Bern
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Key clinical partner in the Swiss public-private hybrid banking pilot project. Collaborates on the hybrid storage service available in clinics nationwide.

sscb-stembiotech.ch
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Strategic partner in the hybrid banking model, collaborating on public donation aspects and global registry connectivity through WMDA.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration partner in CELLS Academy for medical professional education in regenerative medicine and minimally invasive surgery techniques.

4Partner Hospitals (nationwide clinics)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partner hospitals providing birth services where the hybrid banking model is available and where samples are collected directly from delivery rooms.

sscb-stembiotech.ch
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-listed cord blood and cord tissue banking company offering family storage of stem cells with similar B2C model targeting expecting parents. Comparable product offering (Umbilical Cord Blood + tissue preservation) and recurring storage revenue model.

TypeDirect peer
Description

Largest US cord blood bank, now part of CooperCompanies, offering family cord blood and tissue banking with premium positioning. Comparable as the dominant scaled player in family cord blood banking.

TypeDirect peer
Description

UK-based cord blood and tissue bank offering family storage services across multiple cell types including cord blood, cord tissue, and placenta. Comparable UK/European B2C family biobank with similar service portfolio.

TypeDirect peer
Description

US-based cord blood and tissue bank offering family banking with multiple processing technology options. Comparable US family cord blood bank with similar B2C positioning and service tiers.

TypeOthers
Description

Cell therapy supply chain management and orchestration software provider serving cell therapy developers and biobanks. Adjacent ecosystem player supporting the same cord blood and cell therapy value chain that SSCB operates in.

6Esperite (The Cell Factory)
TypeDirect peer
Description

European stem cell biobank and cell therapy services company offering family cord blood banking and cell expansion services. Comparable as a European cord blood bank with broader cell therapy ambitions.

TypeDirect peer
Description

US-based cord blood bank offering family cord blood and cord tissue storage with recurring storage fees. Directly comparable business model and target customer (expectant parents) with established brand recognition.

TypeDirect peer
Description

Europe's largest cord blood bank operating across multiple countries with PBMSC, cord tissue, and regenerative medicine services. Directly comparable to SSCB as a multi-service family stem cell bank with similar B2C model and European footprint.

TypeDirect peer
Description

UK-based stem cell bank focused on umbilical cord blood and tissue storage with international shipping capabilities. Comparable as a European-focused family stem cell storage provider.

TypeBroad incumbent
Description

US-listed supplier of cryopreservation media, storage products, and cold chain solutions for the cell and gene therapy industry. Comparable as an adjacent/ecosystem player in the cryopreservation value chain serving similar biobank and cell therapy customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Swiss Stem Cells Biotech

Stem Cell Biobank Servicessscb-stembiotech.com

Swiss Stem Cells Biotech is a Swiss private biobank founded in 2005, offering cryopreservation of cord blood, adipose tissue, PBMCs, and DNA to consumers and healthcare partners, with FACT-NETCORD accreditation and a unique FOPH-approved hybrid banking model.

What Swiss Stem Cells Biotech does

Swiss Stem Cells Biotech (SSCB) is a Swiss private biobank founded in 2005 in Lugano, Switzerland, specializing in the cryopreservation of biological materials including umbilical cord blood and cord tissue (MyBabyCells), adipose-derived adult stem cells (AdultCells), peripheral blood mononuclear cells for induced pluripotent stem cell generation (EternaCell), and DNA. The company operates as one of the few private biobanks holding FACT-NETCORD accreditation and GMP certification in Switzerland, addressing individual consumers (expecting parents and adult patients), medical professionals, and third-party healthcare companies.

The business model combines one-time processing and collection fees with recurring annual storage subscriptions (with entry pricing from CHF 88), supplemented by DNA storage, contract manufacturing for Advanced Therapy Medicinal Products (ATMPs), and medical training through CELLS Academy. SSCB also operates a hybrid public-private banking model approved by the Swiss Federal Office of Public Health (FOPH) in 2020, partnering with the Women's Clinic of Inselspital in Bern and the Blood Transfusion Service of the Swiss Red Cross.

Distribution is achieved through partner hospitals nationwide and membership in international registries such as the World Marrow Donor Association (WMDA). The company operates with a small team of 1-10 employees from a Swiss headquarters, positioning itself as a "100% Swiss" provider in a trust-sensitive consumer category.

Swiss Stem Cells Biotech firmographics

Firmographics
Name
Swiss Stem Cells Biotech
Legal name
Swiss Stem Cells Biotech
Website
https://sscb-stembiotech.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
51–100 employees
Short description
Swiss Stem Cells Biotech is a Swiss private biobank founded in 2005, offering cryopreservation of cord blood, adipose tissue, PBMCs, and DNA to consumers and healthcare partners, with FACT-NETCORD accreditation and a unique FOPH-approved hybrid banking model.
Ownership category
akta.pro rank

Swiss Stem Cells Biotech industry classification

Industry
Product category
Stem Cell Biobank Services
NAICS
Blood and Organ Banks (621991)
SIC
Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAKAC
Cell Therapy Manufacturing Services (GMP, autologous/allogeneic)

Keywords

  • Stem cell banking
  • Cord blood storage
  • Biobank services
  • Cryopreservation services
  • Regenerative medicine

Where Swiss Stem Cells Biotech is headquartered

Location

Headquarters

HQ city
Vacallo
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

Swiss Stem Cells Biotech business model

Business model
GTM type
B2C
Offering type
Services

Revenue model

  1. Stem Cell Cryopreservation Services: Recurring storage fees for cryopreservation of stem cells from umbilical cord blood, cord tissue, placental tissue, and adipose tissue. One-time processing fees combined with ongoing annual storage charges.
  2. DNA Storage Services: One-time or recurring fees for genetic code preservation services.
  3. Contract Manufacturing (ATMPs): Consultation, development, validation, approval, and production of tissue engineering and advanced biological products on behalf of third parties.
  4. CELLS Academy Training: Courses for medical professionals on regenerative medicine and minimally invasive surgery techniques.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyStem Cell Storage starting from CHF 88

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Swiss Stem Cells Biotech product offering

Product offering

Core offering

Swiss Stem Cells Biotech is a Swiss-certified private biobank that processes and cryopreserves stem cells collected from umbilical cord blood, cord tissue, placental tissue, and adult adipose tissue. Samples are transported directly from partner hospital delivery rooms to its own GMP-certified, FACT-NETCORD accredited laboratory in Switzerland for processing and long-term storage, with a subscription-based storage model complemented by ancillary services such as DNA preservation, contract manufacturing of Advanced Therapy Medicinal Products (ATMPs), and professional training via CELLS Academy.

Product overview

Swiss Stem Cells Biotech operates as a Swiss-certified family biobank offering a portfolio of biological preservation services. The core offerings include MyBabyCells (umbilical cord blood and tissue banking) and AdultCells (adipose tissue stem cell banking for adult patients), supported by specialized services like EternaCell (peripheral blood mononuclear cell preservation) and DNA storage. The company offers contract manufacturing for ATMPs and advanced biological products. CELLS Academy provides educational courses for medical professionals. The Hybrid Banking Model represents a unique public-private partnership enabling family banking with optional anonymous donation to the global WMDA registry.

Differentiator

Problem solved

Functional benefit

Products and services

  • MyBabyCells Stem cell banking service that collects, transports, processes, and cryopreserves stem cells from a newborn's umbilical cord blood and cord tissue for potential future family therapeutic use.
  • AdultCells
  • EternaCell
  • Hybrid Banking Model Combined family protection and public donation model that allows cord blood samples to be entered into the World Marrow Donor Association (WMDA) global registry with explicit consent.
  • DNA Storage
  • Contract Manufacturing (ATMPs)
  • CELLS Academy

Quantifiable outcome

  • Applications in more than 80 established diseases
  • +1 more outcomes

Companies that use Swiss Stem Cells Biotech

Customer profile

Segments4 records

Ideal customer profiles4 records

Swiss Stem Cells Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Swiss Stem Cells Biotech partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Women's Clinic of Inselspital in BerncoreStrategic or Co-development Partner · 1 January 2020Key clinical partner in the Swiss public-private hybrid banking pilot project. Collaborates on the hybrid storage service available in clinics nationwide.
  • Blood Transfusion Service of the Swiss Red Cross (SRC)coreStrategic or Co-development Partner · 1 January 2020Strategic partner in the hybrid banking model, collaborating on public donation aspects and global registry connectivity through WMDA.
  • Swiss Stem Cells FoundationcoreStrategic or Co-development PartnerCollaboration partner in CELLS Academy for medical professional education in regenerative medicine and minimally invasive surgery techniques.
  • Partner Hospitals (nationwide clinics)minorChannel Partner/ Reseller/ DistributorPartner hospitals providing birth services where the hybrid banking model is available and where samples are collected directly from delivery rooms.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Swiss Stem Cells Biotech competitors and assessment

Company assessment

Direct peers

  • Cryo-Cell International: US-listed cord blood and cord tissue banking company offering family storage of stem cells with similar B2C model targeting expecting parents. Comparable product offering (Umbilical Cord Blood + tissue preservation) and recurring storage revenue model.
  • Cord Blood Registry (CBR): Largest US cord blood bank, now part of CooperCompanies, offering family cord blood and tissue banking with premium positioning. Comparable as the dominant scaled player in family cord blood banking.
  • Cells4Life: UK-based cord blood and tissue bank offering family storage services across multiple cell types including cord blood, cord tissue, and placenta. Comparable UK/European B2C family biobank with similar service portfolio.
  • Americord Registry: US-based cord blood and tissue bank offering family banking with multiple processing technology options. Comparable US family cord blood bank with similar B2C positioning and service tiers.
  • Esperite (The Cell Factory): European stem cell biobank and cell therapy services company offering family cord blood banking and cell expansion services. Comparable as a European cord blood bank with broader cell therapy ambitions.
  • ViaCord: US-based cord blood bank offering family cord blood and cord tissue storage with recurring storage fees. Directly comparable business model and target customer (expectant parents) with established brand recognition.
  • FamiCord: Europe's largest cord blood bank operating across multiple countries with PBMSC, cord tissue, and regenerative medicine services. Directly comparable to SSCB as a multi-service family stem cell bank with similar B2C model and European footprint.
  • Smart Cells International: UK-based stem cell bank focused on umbilical cord blood and tissue storage with international shipping capabilities. Comparable as a European-focused family stem cell storage provider.

Others

  • TrakCel: Cell therapy supply chain management and orchestration software provider serving cell therapy developers and biobanks. Adjacent ecosystem player supporting the same cord blood and cell therapy value chain that SSCB operates in.

Broad incumbents

  • BioLife Solutions: US-listed supplier of cryopreservation media, storage products, and cold chain solutions for the cell and gene therapy industry. Comparable as an adjacent/ecosystem player in the cryopreservation value chain serving similar biobank and cell therapy customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Swiss Stem Cells Biotech social profiles

Digital presence

Swiss Stem Cells Biotech compliance and trust

Trust signal

Compliance2 records

Swiss Stem Cells Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Swiss Stem Cells Biotech leadership team

Management profile

Number of profiles

Swiss Stem Cells Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Swiss Stem Cells Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Swiss Stem Cells Biotech

What does Swiss Stem Cells Biotech do?

Swiss Stem Cells Biotech is a Swiss-certified private biobank that processes and cryopreserves stem cells collected from umbilical cord blood, cord tissue, placental tissue, and adult adipose tissue. Samples are transported directly from partner hospital delivery rooms to its own GMP-certified, FACT-NETCORD accredited laboratory in Switzerland for processing and long-term storage, with a subscription-based storage model complemented by ancillary services such as DNA preservation, contract manufacturing of Advanced Therapy Medicinal Products (ATMPs), and professional training via CELLS Academy.

Is Swiss Stem Cells Biotech a public or private company?

Swiss Stem Cells Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Swiss Stem Cells Biotech founded?

Swiss Stem Cells Biotech was founded in 2005. It employs 51 to 100 people.

Where is Swiss Stem Cells Biotech based?

Swiss Stem Cells Biotech is headquartered in Vacallo, Switzerland, in the Europe region.

How does Swiss Stem Cells Biotech make money?

Four revenue lines are on record. Stem Cell Cryopreservation Services are the primary driver. The others are DNA Storage Services, contract Manufacturing (ATMPs) and CELLS Academy Training.

Who are Swiss Stem Cells Biotech's main competitors?

Direct peers on record are Cryo-Cell International, Cord Blood Registry (CBR), Cells4Life, Americord Registry, Esperite (The Cell Factory), ViaCord, FamiCord and Smart Cells International. TrakCel is listed as an others. BioLife Solutions is listed as a broad incumbent.

Does Swiss Stem Cells Biotech have an API?

No public API is recorded for Swiss Stem Cells Biotech.

What industry is Swiss Stem Cells Biotech in?

Swiss Stem Cells Biotech's product category is Stem Cell Biobank Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAAAKAC, Cell Therapy Manufacturing Services (GMP, autologous/allogeneic). Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales